Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001615774-17-005388
Filing Date
2017-09-27
Accepted
2017-09-27 16:02:53
Documents
1
Effectiveness Date
2017-09-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9301
  Complete submission text file 0001615774-17-005388.txt   10532
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-295504 | Film No.: 171104303
SIC: 2834 Pharmaceutical Preparations